Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
about
Interventions for erythropoietin-resistant anaemia in dialysis patientsInterventions for erythropoietin-resistant anaemia in dialysis patientsInterventions for erythropoietin-resistant anaemia in dialysis patientsUnexplained anemia in the elderlyImmune dysfunction in uremia—an updateHemaMax™, a recombinant human interleukin-12, is a potent mitigator of acute radiation injury in mice and non-human primatesOxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial.Protective effect of anthocyanin-rich extract from bilberry (Vaccinium myrtillus L.) against myelotoxicity induced by 5-fluorouracil.Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia.Hepcidin antagonists for potential treatments of disorders with hepcidin excess.Oncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patients.Erythropoietin-induced erythroid precursor pool depletion causes erythropoietin hyporesponsiveness.Organic effects of associating paclitaxel with a lipid-based nanoparticle system on a nonhuman primate, Cebus apella.V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients.The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questionsAssociation between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors.The relationship between Type D personality, affective symptoms and hemoglobin levels in chronic heart failureIL-1β receptor antagonist reduces inflammation in hemodialysis patientsTherapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filtersThe anaemia of silent diabetic nephropathy-prevalence, physiopathology, and management.Anemia and heart failure: a cause of progression or only a consequence?Characteristics and effects of inflammation in end-stage renal disease.Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patientsResistance of dialyzed patients to erythropoietin.Mechanisms and treatment of anemia in chronic heart failure.Molecular pathogenesis of anemia of chronic disease.Circulating growth arrest-specific protein 6 levels are associated with erythropoietin resistance in hemodialysis patients.Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis PatientsSafety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjectsIron Status of Cats with Chronic Kidney Disease.Reversing the risk factor paradox: is daily nocturnal hemodialysis the solution?Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.Red Cell Distribution Width and Mortality in Hemodialysis Patients.Heart failure and anemia: mechanisms and pathophysiology.Association of secondary hyperparathyroidism with hemoglobin level in patients with chronic kidney disease.2. Inflammation, Cytokines and Chemokines in Chronic Kidney Disease.Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.Oxidative stress in Fanconi anemia hematopoiesis and disease progression.Optimizing anemia management in hospitalized patients with end-stage renal disease.Erythropoietic stress and anemia in diabetes mellitus.
P2860
Q24200248-EEEBDC3D-8BA6-4E8A-BA91-5905FEA3C901Q24241704-AFCB7635-DEFB-4118-A745-4FFC4A43FBEEQ24243229-F919212C-530D-466B-BDB6-D1B9C23E7CFCQ24654893-BAF83218-87FC-4BD1-922A-E1C073285FBEQ26829076-C9DE9861-AFA0-4D52-A95D-DF6DAA46BE3CQ28731776-E5916829-35F9-48BA-9E77-EA5B3CEAF430Q33356816-2FA33D5E-12C7-4C46-8723-3621FFD26E5EQ33375785-50021DF0-8129-4BE5-82F4-7612A8030954Q33398338-1C3A7FC7-8251-4EB7-A20D-7E99CF66552EQ33563777-7BE29EDC-464C-4F1B-9FE5-F9AD9D403E0EQ33625452-C6544270-2EB9-4CEC-A47B-13B173FDCCC1Q33655326-06C81917-1E2E-48EF-937B-DD75241950C7Q33719235-BA4F6C09-D2E6-4AB5-AB5C-FDC6C1A25C61Q33892626-0D595836-AE2D-4700-961B-AAC6AA9E1CB8Q34065957-2FC632D0-BF13-4866-81AB-95797E9AF669Q34094710-56151963-15B0-43D1-8C20-392A6EC66668Q34614964-DC5CA887-3F30-407F-B353-D283BF684822Q34695324-2B15193B-6347-47EF-8AE3-86B86DC7763FQ35164180-7FA67B7C-38F8-4211-A269-9C0153B09CA2Q35208122-0D7D3227-4280-4FC9-B340-D89662CB6F53Q35252704-8CFCDB5A-3E6B-42BB-93B1-99F4C2FFA266Q35589530-A0280DEB-BA9D-46D2-83FC-FA58748E9D8FQ35653263-1FF1F26C-7715-444E-A13C-6AED66F77D36Q35694046-09B9B5BB-ABFB-4F3F-9BFC-D465BB3CB17CQ35911432-458E985A-AD0F-4C57-9276-1B35F94A746EQ36302532-2F3E064E-BB29-4E55-8FAD-865E0B096B22Q36456252-BCC0C292-7C8B-46D8-8169-F56ED527DD9DQ36746098-E196E4FD-82F3-4A17-8309-3BEBB39112E7Q36830103-F2885B7E-BEC5-4EC2-94F2-5D211106194BQ36975638-4A62105A-5A33-4801-ABA3-25E0E9E1949DQ36996692-CF0B9184-009E-4EB4-BF12-E2F72C0B68E7Q37038424-E5984A17-F41E-48C4-9081-5B6376FD8D80Q37038766-2055BA6C-22F6-42D4-B612-AAA91BE14AE0Q37072561-06B23A95-3277-4180-A218-6FB6978D077EQ37136019-0CDCD791-9728-494D-9801-4B882DDCCEABQ37155228-E43F1F1B-20C7-4302-A618-59C84D8247C1Q37211057-AF8DF45C-3079-43FA-93CF-E492D1B6FCE9Q37216681-67AA4A33-17B7-4E88-B11B-D6565F6A5E45Q37367706-254C8F55-B9D2-4169-BF0F-77DA23B43476Q37437142-A4AA565C-1E38-427B-8095-88130D6BC30F
P2860
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
@ast
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
@en
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
@nl
type
label
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
@ast
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
@en
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
@nl
prefLabel
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
@ast
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
@en
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
@nl
P356
P1476
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
@en
P2093
Angela C Cooper
Iain C Macdougall
P356
10.1093/NDT/17.SUPPL_11.39
P407
P478
17 Suppl 11
P577
2002-01-01T00:00:00Z